the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

Also called NCT02158559

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02158559
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02158559. Randomized; double masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.
Acronym
Danhong
Intervention (Drug)
Danhong Injection
Intervention (Drug)
Normal Saline
Lead sponsor
Beijing Bozhiyin T&S Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02158559
Content hash
00ade1bd9730a794cb11ae1e9293732b3487bb20f90f73b44454f475736b8496